Bruker Corporation BRKR recently announced the launch of the neofleX Imaging Profiler for mass spectrometry-based tissue imaging at the 72nd ASMS meeting.The novel, high-performance MALDI-TOF/TOF ...

neofleX is a versatile, high-performance, and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers neofleX Imaging Profiler MALDI-TOF/TOF with proprietary ...

Bruker Corporation BRKR recently announced a collaboration and quality agreement with the medical device company, Accelerate Diagnostics Inc. AXDX.

Bruker Corporation BRKR recently announced a collaboration and quality agreement with the medical device company, Accelerate Diagnostics Inc. AXDX. The agreement enables the validation of Bruker’s ...

1. Bruker introduces fast next-generation MALDI Biotyper IVD Software. Microbial identification faster than ever: The MBT Compass HT IVD software provides a high sample throughput for microbial ...

At the 33rd European Congress of Clinical Microbiology & Infectious Diseases (www.eccmid.org), Bruker Corporation (Nasdaq: BRKR) announced its latest innovations for user-friendly, best-in-class ...

Dr. Wolfgang Pusch, President of the Bruker Microbiology & Infection Diagnostics division, commented: “With the introduction of our new IVD workflows, kits, software and reference libraries for ...

Combined with Bruker’s unique ultra-high speed (10 kHz), high-spatial resolution (5 µm) MALDI imaging mass spectrometers, such as Bruker’s rapifleX® and timsTOF fleX™ systems, the new Miralys ...

The new timsTOF® MPP is now the flagship of Bruker´s MALDI PharmaPulse product family which became a game changer in the HTS market with the launch of the rapifleX MPP, a MALDI-TOF-based label ...